India's drug regulator has intensified surveillance over GLP-1 weight loss drugs following the March patent expiry of ...

India drug regulator cracks down on misuse of GLP 1 weight loss drugs, expanding inspections and warnings as demand surges ...

The Drug Controller General of India has stepped up regulatory surveillance against unauthorised sale and promotion of type 2 ...

The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but ...

Amid continued violations and the widespread misuse and easy availability of weight loss drugs in the market, the Centre on ...

IN BANGLADESH today, e-commerce is transforming the way people shop. With a growing number of consumers using online ...

The Indian government has issued a strong warning against the misuse of glucagon-like peptide-1 receptor agonists (GLP-1) ...

The GLP-1 based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity but carry serious ...

India warns of GLP-1 drug risks as Ozempic and Wegovy prices fall, urging prescription-only use and tightening checks on ...

The Indian government has released details on GLP-1 drugs for diabetes and obesity, explaining their function and risks. Amid ...

A lawyer's ad for her sexual harassment law firm was initially rejected by Syracuse Hancock International Airport. Following ...

A new analysis by three Dutch civil-society groups argues that brand promises of ethical workplaces can mislead consumers.